Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PO-001 versus Cystagon and Procysbi pharmacokinetic crossover study in healthy adults
NL-OMON48026Completed
- Sponsor
- PatientOne
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of PO-001 in cystinosis (3 arms), sponsored by PatientOne. Primary endpoints: Treatment-emergent adverse events, Clinical laboratory tests and 10 more. Started Oct 2019; status: completed.
02
Drugs
PO-001
03
Conditions
cystinosis
Beyond the preview
Go deeper on NL-OMON48026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48026.